236 related articles for article (PubMed ID: 35984764)
21. Ventricular-Arterial Coupling and Exercise-Induced Pulmonary Hypertension During Low-Level Exercise in Heart Failure With Preserved or Reduced Ejection Fraction.
Obokata M; Nagata Y; Kado Y; Kurabayashi M; Otsuji Y; Takeuchi M
J Card Fail; 2017 Mar; 23(3):216-220. PubMed ID: 27737768
[TBL] [Abstract][Full Text] [Related]
22. Comparison of characteristics and outcomes of patients with heart failure preserved ejection fraction versus reduced left ventricular ejection fraction in an urban cohort.
Quiroz R; Doros G; Shaw P; Liang CS; Gauthier DF; Sam F
Am J Cardiol; 2014 Feb; 113(4):691-6. PubMed ID: 24484862
[TBL] [Abstract][Full Text] [Related]
23. Renal Sympathetic Denervation in Patients With Heart Failure With Preserved Ejection Fraction.
Kresoja KP; Rommel KP; Fengler K; von Roeder M; Besler C; Lücke C; Gutberlet M; Desch S; Thiele H; Böhm M; Lurz P
Circ Heart Fail; 2021 Mar; 14(3):e007421. PubMed ID: 33706547
[TBL] [Abstract][Full Text] [Related]
24. Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial.
Edelmann F; Musial-Bright L; Gelbrich G; Trippel T; Radenovic S; Wachter R; Inkrot S; Loncar G; Tahirovic E; Celic V; Veskovic J; Zdravkovic M; Lainscak M; Apostolović S; Neskovic AN; Pieske B; Düngen HD;
JACC Heart Fail; 2016 Feb; 4(2):140-149. PubMed ID: 26682793
[TBL] [Abstract][Full Text] [Related]
25. Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST-CHF study.
Eidizadeh A; Schnelle M; Leha A; Edelmann F; Nolte K; Werhahn SM; Binder L; Wachter R
ESC Heart Fail; 2023 Feb; 10(1):200-210. PubMed ID: 36184749
[TBL] [Abstract][Full Text] [Related]
26. Impaired cardiopulmonary baroreflex function and altered cardiovascular responses to hypovolemia in patients with heart failure with preserved ejection fraction.
Alpenglow JK; Bunsawat K; Francisco MA; Craig JC; Iacovelli JJ; Ryan JJ; Wray DW
J Appl Physiol (1985); 2024 Mar; 136(3):525-534. PubMed ID: 38174372
[TBL] [Abstract][Full Text] [Related]
27. Comparison of 5-Year Outcomes After Coronary Artery Bypass Grafting in Heart Failure Patients With Versus Without Preserved Left Ventricular Ejection Fraction (from the CREDO-Kyoto CABG Registry Cohort-2).
Marui A; Nishiwaki N; Komiya T; Hanyu M; Tanaka S; Kimura T; Sakata R;
Am J Cardiol; 2015 Aug; 116(4):580-6. PubMed ID: 26092271
[TBL] [Abstract][Full Text] [Related]
28. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy.
Schwartzenberg S; Redfield MM; From AM; Sorajja P; Nishimura RA; Borlaug BA
J Am Coll Cardiol; 2012 Jan; 59(5):442-51. PubMed ID: 22281246
[TBL] [Abstract][Full Text] [Related]
29. Rationale and design of the phase 2b clinical trials to study the effects of the partial adenosine A1-receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced (PANTHEON) and preserved (PANACHE) ejection fraction.
Voors AA; Shah SJ; Bax JJ; Butler J; Gheorghiade M; Hernandez AF; Kitzman DW; McMurray JJV; Wirtz AB; Lanius V; van der Laan M; Solomon SD
Eur J Heart Fail; 2018 Nov; 20(11):1601-1610. PubMed ID: 30225882
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Predictors of Heart Failure With Preserved Versus Reduced Ejection Fraction in a Multiracial Cohort of Preclinical Left Ventricular Diastolic Dysfunction.
Zhang L; Liebelt JJ; Madan N; Shan J; Taub CC
Am J Cardiol; 2017 Jun; 119(11):1815-1820. PubMed ID: 28450040
[TBL] [Abstract][Full Text] [Related]
31. Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion.
Van Aelst LNL; Arrigo M; Placido R; Akiyama E; Girerd N; Zannad F; Manivet P; Rossignol P; Badoz M; Sadoune M; Launay JM; Gayat E; Lam CSP; Cohen-Solal A; Mebazaa A; Seronde MF
Eur J Heart Fail; 2018 Apr; 20(4):738-747. PubMed ID: 29251818
[TBL] [Abstract][Full Text] [Related]
32. Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach.
Kanagala P; Arnold JR; Singh A; Chan DCS; Cheng ASH; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
PLoS One; 2020; 15(4):e0232280. PubMed ID: 32349122
[TBL] [Abstract][Full Text] [Related]
33. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
[TBL] [Abstract][Full Text] [Related]
34. Effect of endurance exercise training on endothelial function and arterial stiffness in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial.
Kitzman DW; Brubaker PH; Herrington DM; Morgan TM; Stewart KP; Hundley WG; Abdelhamed A; Haykowsky MJ
J Am Coll Cardiol; 2013 Aug; 62(7):584-92. PubMed ID: 23665370
[TBL] [Abstract][Full Text] [Related]
35. Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction.
Valero-Munoz M; Li S; Wilson RM; Boldbaatar B; Iglarz M; Sam F
Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27810862
[TBL] [Abstract][Full Text] [Related]
36. Circulating Neprilysin in Patients With Heart Failure and Preserved Ejection Fraction.
Lyle MA; Iyer SR; Redfield MM; Reddy YNV; Felker GM; Cappola TP; Hernandez AF; Scott CG; Burnett JC; Pereira NL
JACC Heart Fail; 2020 Jan; 8(1):70-80. PubMed ID: 31392960
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of Heart Failure With Preserved Ejection Fraction Across the Range of Left Ventricular Ejection Fraction.
Rosch S; Kresoja KP; Besler C; Fengler K; Schöber AR; von Roeder M; Lücke C; Gutberlet M; Klingel K; Thiele H; Rommel KP; Lurz P
Circulation; 2022 Aug; 146(7):506-518. PubMed ID: 35862208
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for heart failure are associated with alterations of the LV end-diastolic pressure-volume relationship in non-heart failure individuals: data from a large-scale, population-based cohort.
Schwarzl M; Ojeda F; Zeller T; Seiffert M; Becher PM; Munzel T; Wild PS; Blettner M; Lackner KJ; Pfeiffer N; Beutel ME; Blankenberg S; Westermann D
Eur Heart J; 2016 Jun; 37(23):1807-14. PubMed ID: 27055814
[TBL] [Abstract][Full Text] [Related]
39. Understanding heterogeneous mechanisms of heart failure with preserved ejection fraction through cardiorenal mathematical modeling.
Basu S; Yu H; Murrow JR; Hallow KM
PLoS Comput Biol; 2023 Nov; 19(11):e1011598. PubMed ID: 37956217
[TBL] [Abstract][Full Text] [Related]
40. Impact of elevated heart rate on clinical outcomes in patients with heart failure with reduced and preserved ejection fraction: a report from the CHART-2 Study.
Takada T; Sakata Y; Miyata S; Takahashi J; Nochioka K; Miura M; Tadaki S; Shimokawa H;
Eur J Heart Fail; 2014 Mar; 16(3):309-16. PubMed ID: 24464774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
